Adam, T., Mitschke, S., Streibel, T., Baker, R.R., Zimmermann, R. (2006). Quantitative Puff-by-Puff-resolved characterization of selected toxic compounds in cigarette mainstream smoke. Chem. Res.
Toxicol.: 19 (4), 511-520.
Aktories, K., Förstermann, U., Hofmann, F.B., Starke K. (Hrsg.), Allgemeine und spezielle Pharmakologie und Toxikologie. Urban und Fischer (München, Deutschland), 2004. ISBN-13: 978-3437425219.
Andersen, F.A. (1994). Final report on the safety assessment of propylene glycol and propylene glycols. J. Am. Coll. Toxicol.: 1994 (6), 437–91.
Baek, S., Jenkins, R.A. (2004). Characterization of trace organic compounds associated with aged and diluted sidestream tobacco smoke in controlled atmosphere-volatile organic compounds and polycyclic aromatic hydrocarbons. Atmospheric Environment: 38, 6583-6599.
Baker, R.R. (1999). Smoke chemistry. Tobacco: Production, Chemistry, and Technology (Davis, L.D., and Nielsen, M.T., Eds.), pp 398-439.
Barnoya, J., Glantz, S.A. (2005). Cardiovascular Effects of second hand smoke Nearly as large as smoking. Circulation: 111; 2684-2698.
Becker, N., Wahrendorf, J. (1998). Krebsatlas der Bundesrepublik Deutschland 1981-1990. Springer, Berlin, Heidelberg, New York, 1998.
Benowitz, N.L., Jacob P. 3rd (1994). Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin. Pharmacol. Ther.: 56, 483–493.
Benowitz, N.L. (2008). Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther.: 83, 531–541.
Benwell, M.E., Balfour, D.J., Anderson, J.M. (1988). Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J. Neurochem.: 50 (4), 1243-7.
Bernstein, D.M. (2004). A review of the influence of particle size, puff volume, and inhalation pattern on the deposition of cigarette smoke particles in the respiratory tract. Inhalation Toxicol.: 16, 675-689.
Bohac, D.L., Hewett, M.J., Kapphahn, K.I., Grimsrud, D.T., Apte, M.G., Gundel, L.A. (2010). Change in indoor particle levels after a smoking ban in Minnesota Bars and restaurants. Am. J. Prev. Med.: 39, 3–9.
41 Bullen, C., McRobbie, H., Thornley, S., Glover, M., Lin, R., Laugesen, M. (2010). Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomized cross-over trial. Tob. Control.: 19 (2), 98-103.
Bundesinstitut für Risikobewertung (2006). Krebserregende Wirkung von eingeatmetem Formaldehyd hinreichend belegt 14/2006, 29.05.2006.
Bundesinstitut für Risikobewertung (2012a). Liquids von E-Zigaretten können die Gesundheit beeinträchtigen. Stellungnahme Nr. 016/2012 des BfR vom 24. Februar 2012.
Bundesinstitut für Risikobewertung (2012b). E-Zigaretten können auch zu gesundheitlichen Gefahren für Passivraucher führen. Pressemitteilung 17/2012, 07.05.2012.
Cinciripini, P.M., Hecht, S.S., Henningfield, J.E., Manley, M.W., Kramer, B.S. (1997). Tobacco addiction: implications for treatment and cancer prevention. J. Natl. Cancer Inst.: 89 (24), 1852-67.
Connolly, G.N., Alpert, H.R., Wayne, G.F., Koh, H. (2007). Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997-2005. Tob. Control.:
16 (5), e5.
Dawkins, L., Turner, J., Hasna, S., Soar, K. (2012). The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition. Addict. Behav.: 37 (8), 970-3.
Deutsches Krebsforschungszentrum (Hrsg.). Durch Rauchen und Passivrauchen verursachte Krebserkrankungen; Heidelberg, 2008.
Djordjevic, M.V., Stellman, S.D., Zang, E. (2000). Doses of nicotine and lung carcinogens delivered to cigarette smokers. J. Natl. Cancer Inst.: 92 (2), 106-11.
Doll, R., Hill, A.B. (1950). Smoking and carcinoma of the lung. Preliminary report. Br. Med. J.:2, 739.
Doll, R. (1998). The first reports on smoking and lung cancer. Clio Med.: 46, 130–142.
Ebner, N., Földes, G., Szabo, T., Tacke, M., Fülster, S., Sandek, A., Doehner, W., Anker, W., von Haehling, S. (2012). Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behavior. Clin. Res. Cardiol.: DOI 10.1007/s00392-012-0499-0.
Etter L. (2011). Controversy swirls around e-cigarettes. The Wall Street Journal: 2 June 2009.
Available at: http://online.wsj.com/article/SB124390176699074609.html (accessed May 2011).
Etter, J.F., Bullen, C. (2011a). Saliva cotinine levels in users of electronic cigarettes. European Respiratory Journal: 38, 1219–1220.
42 Etter, J.F., Bullen, C. (2011b). Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy.Addiction:106 (11), 2017-28.
Fitzmaurice, P. (2008). Heavy metal testing of Ruyan cartridge liquid. Inductively coupled plasma mass spectrometry (ICP-MS). Environmental Science and research (ESR), Porirura 2008.
Gleich, F., Mons, U., Pötschke-Langer, M. (2011). Air contamination due to smoking in German restaurants, bars, and other venues-before and after the implementation of a partial smoking ban, Nicotine Tob. Res.: 13, 1155–1160.
Goniewicz, M.L., Kuma, T., Gawron, M., Knysak, J., Kosmider, L. (2012). Nicotine Levels in Electronic Cigarettes. Nicotine Tob. Res.: 22, 1-9.
Hadwiger, M.E., Trehy, M.L., Ye, W., Moore, T., Allgire, J., Westenberger, B. (2010). Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. Journal of Chromatography A: 48, 7547–7555.
Haustein, K.O. (2001). Tabakabhängigkeit. Gesundheitliche Schäden durch das Rauchen.
Ursachen-Folgen–Behandlungsmöglichkeiten–Konsequenzen für Politik und Gesellschaft. Deutscher Ärzte-Verlag, Köln.
Hecht, S.S. (1999). Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst.: 91, 1194–1210.
Hoffmann, D., Hoffmann, I., El-Bayoumy, K. (2001). The less harmful cigarette: A controversal issue.
A tribute to Ernst L. Wynder. Chem. Res. Tox.: 14 (7), 767–790.
Hoffmann, D., Schmeltz, I., Hecht, S.S., Wynder, E. L. (1978). Tobacco carcinogenesis. In: Gelboin, H. V. und Ts’o, P. O. P. (Hrsg.): Polycyclic Hydrocarbons and Cancer 1. Environment, chemistry, and metabolism. Academic Press, New York, NY. 85–117.
Hoffmann, D., Hoffmann, I. (1997). The changing cigarette, 1950–1995. Journal of Toxicology and Environmental Health: 50, 307–364.
Hort research, Polycyclic aromatic hydrocarbons in Ruyan e-cigarettes. Analysed 17 March 2008.
Hughes, J.R., Keely, J., Naud, S. (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction: 99 (1), 29-38.
International Agency for Research on Cancer. (2002). Tobacco Smoke and Involuntary Smoking.
Lyon, France: 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Vol. 83.
43 International Agency for Research on Cancer (2004). Tobacco smoke and involuntary smoking. IARC Monographs on the evaluation of the carcinogenic risks to humans. Vol. 83. International Agency for Research on Cancer, World Health Organization, Lyon, S. 59ff, S.1103ff, S. 1180ff, S.1191ff.
Lamb, J. (1997). Reproductive toxicology. Propylene glycol. Environ. Health Perspect.: 105 (suppl 1), 231–2.
Laugesen, M. (2008a). Second Safety Report on the Ruyan® e-cigarette. Health New Zealand Ltd.
Laugesen, M. (2008b). Safety report on the Ruyan e-cigarette cartridge and inhaled aerosol.
Christchurch, New Zealand: Health New Zealand Ltd, 2008.
Laugesen, M. (2009). Ruyan ® E-cigarette Bench-top tests, Poster 5-11, Society for Research on Nicotine and Tobacco (SRNT), Dublin, April 30, 2009.
Mackay, J., Eriksen, M. (2002). The Tobacco Atlas. World Health Organization, Genf.
McAuley, T.R., Hopke, P.K., Zhao, J., Babaian, S. (2012). Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal. Toxicol.: (12), 850-7.
Montharu, J., Le Guellec, S., Kittel, B., Rabemampianina, Y., Guillemain, J., Gauthier, F., Diot, P., de Monte, M. (2010). Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols. J. Aerosol. Med. Pulm. Drug. Deliv.: 23, 41–46.
National Cancer Institute. (1999). Health Effects of Exposure to Environmental Tobacco Smoke.
Bethesda, MD: National Cancer Institute. Smoking and Tobacco Control Monograph 10.
O’Brien, K.L., Selanikio, J.D., Hecdivert, C., Placide, M.F., Louis, M., Barr, D.B., Barr, J.R., Hospedales, C.J., Lewis, M.J., Schwartz, B., Philen, R.M., St Victor, S., Espindola, J., Needham, L.L., Denerville, K. (1998). Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team. JAMA 1998: 279, 1175e80.
Paschke, T., Scherer, G., Heller, W.D. (2002). Effects of ingredients on cigarette smoke composition and biological activity: a literature overview. Beiträge zur Tabakforschung International: 20, 107-247.
Patskan, G., Reininghaus, W. (2003). Toxicological evaluation of an electrically heated cigarette. Part 1: Overview of technical concepts and summary of findings. J. Appl. Toxicol.: 23 (5), 323-8.
Polosa, R., Caponnetto, P., Morjaria, J.B., Papale, G., Campagna, D., Russo, C. (2011). Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health: 11, 786.
44 Proctor, C., Murphy, J. (2009). Analysis of the Ruyan Classic E-cigarette, British American Tobacco Group R&D, 15. April 2009.
Proctor, R.N. (2001). Tobacco and the global lung cancer epidemic. Nature Reviews Cancer: 1, 82-86.
Rafter, D. (2008). Smokin’ hot. Specialty Retail Report 2008 Fall. Available at:
http://www.specialtyretail.com/2008/fall/ retailer_profiles/smoking_hot_cover_story.
Reichl, F.X. (1997). Taschenatlas der Toxikologie. Substanzen, Wirkungen, Umwelt. Georg Thieme Verlag, Stuttgart, New York
Riess, U., Tegtbur, U., Fauck, C., Fuhrmann, F., Markewitz, D., Salthammer, T. (2010). Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath. Anal. Chim. Acta: 669, 53–62.
Rodgman, A., Perfetti, T.A. (2009). The Chemical Components of Tobacco and Tobacco Smoke. CRC Press, Boca Raton.
Sasco A.J., Secretan M.B., Straif K. (2004). Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer: 45 Suppl. 2, 3–9.
Schectman, G., Byrd, J.C., Gruchow, H.W. (1989). The Influence of Smoking on Vitamin C Status in Adults. American Journal of Public Health: Vol. 79, 158-162.
Schripp, T., Markewitz, D., Uhde, E., Salthammer, T. (2012). Does e-cigarette consumption cause passive vaping? Indoor Air: doi:10.1111/j.1600-0668.2012.00792.
Scientific analysis of E-cigarettes. (2007). British American Tobacco Research&Development, November 2007.
Skaare, A., Kjaerheim, V., Barkvoll, P., Rølla G. (1997). Skin reactions and irritation of four commercial toothpastes. Acta Odontol. Scand.: 55:, 33–6.
Slade, J. (1997). Historical notes on tobacco. Bollinger, C. T. und Fagerström, K. O. (Hrsg.): The tobacco epidemic. Progress in Respiratory Research: 28, Karger, Basel. 1–11.
Sömmering, S. T. (1795). De morbis vasorum absorbentium corporis humani. Varrentrapp & Wenner, Frankfurt/Main., 109.
Stabbert, R., Voncken, P., Rustemeier, K., Haussmann, H.J., Roemer, E., Schaffernicht, H., Patskan, G. (2003). Toxicological evaluation of an electrically heated cigarette. Part 2: Chemical composition of mainstream smoke. J. Appl. Toxicol.: 23 (5), 329-39.
45 Stepanov, I., Jensen, J., Hatsukami, D., Hecht, S.S. (2006). Tobaccospecific nitrosamines in new tobacco products. Nicotine Tob. Res.: 8, 309–13.
Stepanov, I., Carmella, S.G., Briggs, A., Hertsgaard, L., Lindgren, B., Hatsukami, D., Hecht, S.S.
(2009a). Presence of the carcinogen N’-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res.: 69, 8236e40.
Stepanov, I., Carmella, S.G., Han, S., Pinto, A., Strasser, A.A., Lerman, C., Hecht, S.S. (2009b).
Evidence for endogenous formation of N’-nitrosonornicotine in some long-term nicotine patch users.
Nicotine Tob. Res.: 11, 99e105.
Trehy, M.L., Ye, W., Hadwiger, M.E., Moore, T.W., Allgire, J.F., Woodruff, J.T., Ahadi, S.S., Black, J.C., Westenberger, B.J. (2011). Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J. Liq. Chromatogr. Relat. Technol.: 34, 1442–1458.
Trtchounian, A., Williams, M., Talbot, P. (2010). Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob. Res.: 12 (9), 905-12.
U.S. Department of Health and Human Services. (2006). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006.
U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
U.S. Environmental Protection agency (1992). Respiratory health effects of passive smoking (also known as exposure to secondhand smoke or environmental tobacco smoke ETS). U.S. Environmental Protection Agency, Office of Research and Development, Office of Health and Environmental Assessment, Washington, DC, EPA/600/6-90/006F.
van den Heuvel, M. (2012). E-Zigarette: Dunstige Debatte, Doccheck News, 01.06.2012.
Vansickel, A.R., Cobb, C.O., Weaver, M.F., Eissenberg, T.E. (2010). A clinical laboratory model for evaluating the acute effects of electronic ‘cigarettes’: Nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiology, Biomarkers & Prevention: 19, 1945–1953.
Vansickel, A.R., Blank, M., Cobb, C., Kilgalen, B., Austin, J., Weaver, M. et al. (2011) Clinical laboratory model for evaluating the effects of electronic cigarettes. 17th Annual Meeting of the Society for Research on Nicotine and Tobacco. Toronto, Canada, 2011.
46 Varughese, S., Teschke, K., Brauer, M., Chow, Y., van Netten, C., Kennedy, S. M. (2005). Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am. J. Ind. Med.:
47 (5), 411-8.
Westenberger, B.J. (2009). Evaluation of e-cigarettes (pp. 1–8). St. Louis, MO: Food and Drug Administration. Center for Drug Evalation and Research.
Wieslander, G., Norback, D., Lindgren, T. (2001). Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup. Environ. Med.: 58 (10), 649-55.
Wright, G.F. (1967). Studies with tobacco smoke condensate; Proc. 3rd Natl. Cancer Conf., Juni 1956.
J.B. Lippincott, Philadelphia PA, 1967, pp. 479-484.
Wynder, E.L., Graham, E.A. (1950). Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. J. Am. Med. Assoc.: 143, 329–36.
Zezima, K. (2010). Cigarettes without smoke or regulation. New York Times June 1, 2009.
http://www.nytimes.com/2009/06/02/us/02cigarette.html.
47